AIDS Action Statement On Approval of New Treatment for Hepatitis C
BOSTON, Mass.—On Friday, the U.S. Food and Drug Administration (FDA) approved the new drug sofosbuvir for treatment for chronic hepatitis C. This follows last month’s…
chronic hepatitis